Compare AbCellera Biologics Inc (ABCL) vs Appian Corp (APPN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Appian Corp — how do they compare? AbCellera Biologics Inc trades at $9.06 (market cap $2.99B), while Appian Corp trades at $35.5 (market cap $2.54B). The key difference: AbCellera Biologics Inc is the larger of the two by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Appian Corp nearer its low. Which is the better fit depends on your goals.
| ABCL | APPN | |
|---|---|---|
Market Cap | $2.99B | $2.54B |
Sector | Health | Technology |
52-Week High | $9.76 | $45.64 |
52-Week Low | $2.78 | $18.72 |
Enterprise Value | $2.58B | $2.67B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Appian Corp
Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.
Read more on APPN →
